Saniona AB News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

30.04.21	Change in numbers of shares and votes in Saniona AB (publ) (GlobeNewswire)
29.04.21	Saniona publishes its Annual Report for 2020 (GlobeNewswire)
26.04.21	Saniona to Present at Multiple Upcoming Investor Conferences (GlobeNewswire)
23.04.21	Notice of Saniona AB annual shareholders’ meeting (GlobeNewswire)
22.04.21	Saniona announces outcome of TO3 warrant exercise (GlobeNewswire)
22.04.21	Saniona Updates Tesomet Clinical Development Timelines Based on Manufacturing Feedback from U.S. FDA (GlobeNewswire)
19.04.21	Saniona Announces Partnership with the Foundation for Prader-Willi Research (FPWR) to Support its Prader-Willi Syndrome (PWS) Clinical Trial with Tesomet (GlobeNewswire)
14.04.21	Saniona to Present Preclinical Data on SAN903 at the ASPET Annual Meeting at Experimental Biology 2021 (GlobeNewswire)
12.04.21	Saniona Completes Sale of Remaining Shares in Scandion Oncology (GlobeNewswire)
31.03.21	Saniona announces that the exercise period of warrants of series TO3 begins on April 6, 2021 (GlobeNewswire)
19.03.21	Saniona Chairman J. Donald deBethizy and CEO Rami Levin, as well as additional members of the board and management, purchase Saniona shares in the open market (GlobeNewswire)
17.03.21	Saniona publishes its year-end report for 2020 (GlobeNewswire)
15.03.21	Saniona Announces Oral Presentation of Tesomet Data in Hypothalamic Obesity at ENDO 2021 (GlobeNewswire)
10.03.21	Saniona to Present at the Oppenheimer 31st Annual Healthcare Conference (GlobeNewswire)
08.03.21	Saniona Receives Feedback from U.S. FDA Providing a Regulatory Path Forward for Tesomet in Hypothalamic Obesity (GlobeNewswire)
03.03.21	Saniona Receives U.S. FDA Orphan Drug Designation for Tesomet in Prader-Willi Syndrome (GlobeNewswire)
22.02.21	Saniona postpones 2020 year-end financial report due to restatement and re-audit of prior period financial statements in line with U.S. PCAOB audit standards (GlobeNewswire)
25.01.21	Saniona received approximately USD $2.9 million (SEK 24.2 million) upfront payment in connection with Cadent Therapeutics transaction (GlobeNewswire)
07.01.21	Saniona to present at three upcoming investor conferences (GlobeNewswire)
21.12.20	Saniona Appoints Chief Legal Officer and Chief Technical Operations Officer to Its Executive Team (GlobeNewswire)
17.12.20	Saniona was informed today that Novartis plans to acquire Cadent Therapeutics, in which Saniona holds an ownership stake of approximately 3% (GlobeNewswire)
16.12.20	Saniona’s Ownership Stake in Scandion Oncology Reduced Below 5% Following Scandion’s Successful Rights Issue (GlobeNewswire)
30.11.20	Saniona publishes its interim report for the third quarter 2020 (GlobeNewswire)
26.11.20	Saniona AB’s Nomination Committee for the Annual General Meeting 2021 (GlobeNewswire)
23.11.20	Saniona Reports Positive Topline Results from Tesomet Phase 2 Open-Label Extension Study in Hypothalamic Obesity (GlobeNewswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Saniona AB

Aktien Top/Flop

Meistgelesene Nachrichten